LIVZON PHARMA (01513): Ran Yongmei appointed as a member of the Board's Strategic Committee.
Li Zhu Pharmaceutical (01513) announced that on March 24, 2026, Ms. Dong Yongmei, a representative of the company's employees, has been appointed as a member of the Board's Strategic Committee, and Mr. Tang Yanggang, Executive Director, has been appointed as a member of the Nominating Committee of the Board, effective from March 24, 2026.
LIVZON PHARMA (01513) announced that on March 24, 2026, Ms. Dong Yongmei, a representative of the company's employees, has been appointed as a member of the Board's Strategic Committee, and Mr. Tang Yanggang, an executive director, has been appointed as a member of the Board's Nomination Committee, effective from March 24, 2026.
Related Articles
CIRRUS (02507) will distribute a final dividend of $0.12 per share on July 16th.
HUANENG POWER (00902): Huang Chaoquan resigns as company secretary and authorized representative.
RECBIO-B(02179): Wei Qifang and Sun Jiaen have been appointed as joint company secretaries.
CIRRUS (02507) will distribute a final dividend of $0.12 per share on July 16th.
HUANENG POWER (00902): Huang Chaoquan resigns as company secretary and authorized representative.
RECBIO-B(02179): Wei Qifang and Sun Jiaen have been appointed as joint company secretaries.
RECOMMEND
Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026
Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026
Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026
